PUBLISHER: Grand View Research | PRODUCT CODE: 1511899
PUBLISHER: Grand View Research | PRODUCT CODE: 1511899
The global disposable bronchoscope market size is expected to reach USD 1.69 billion by 2030, growing at a CAGR of 13.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing incidence rate of chronic respiratory disorders, such as COPD, lung stenosis, lung cancer, tumors, bronchitis, pneumonia, and lung infections are driving market growth. Moreover, the increasing demand for same day surgeries or minimally invasive procedures, which result in shortened hospitalization, quicker recovery, and reduced postoperative care is fostering the growth. The growing awareness levels towards the reduced infection and contamination rate of using disposable bronchoscopes is positively impacting the growth. Frequent product approvals are broadening the product portfolio of key players and catering to the growing need for disposable bronchoscopes.
Several key factors, including the rising incidence of respiratory diseases, the growing prevalence of smoking, and increased product approvals, are significantly contributing to the growth of the market. As the number of respiratory ailments continues to increase, the demand for bronchodilators and related treatments is expected to surge. For instance, as per a 2024 NIH report, acute bronchitis is one of the top 10 most common outpatient illnesses in the U.S., affecting about 5% of adults annually. Consequently, the escalating burden of bronchitis is fueling the demand for effective bronchitis treatment, which in turn, is driving market growth.
The rising prevalence of various respiratory disorders serves as a primary growth driver for the market. The American Cancer Society, Inc. reports that there will be 234,580 new cases of lung cancer and tumors in the U.S., resulting in 125,070 deaths from lung cancer. This rise in lung cancer cases will lead to an increased demand for bronchoscopies to detect and treat lung cancers. Similarly, Cancer Research UK reveals 48,500 new lung cancer cases diagnosed annually. With 58.7% of lung cancer cases occurring in developing countries (as per World Cancer Research Fund International), the global demand for bronchoscopies is anticipated to grow significantly. Furthermore, the potential risks of infection and contamination associated with reusable bronchoscopes create lucrative opportunities for the adoption and expansion of disposable bronchoscope technologies.